GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 8/7/2026 7:24:10 AM | Small | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $45,376,000 -4.2% | Assets $181,055,000 | EPS -$0.24 | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 8/7/2026 7:11:32 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $45,376,000 -4.2% | Assets $181,055,000 | EPS -$0.24 | Export Earnings Model | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 5/8/2026 7:23:47 AM | Small | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $47,198,000 -10.2% | Assets $184,102,000 | EPS -$0.28 | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 5/8/2026 7:06:29 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $47,198,000 -10.2% | Assets $184,102,000 | EPS -$0.28 | Export Earnings Model | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 4/6/2026 8:50:20 AM | View | Proxy | SEC | Y 2025 | ||||||
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 2/27/2026 7:21:40 AM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $212,690,000 +1.6% | Assets $190,581,000 | EPS -$0.93 | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 2/27/2026 7:20:14 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $62,519,000 -9.0% | Assets $190,581,000 | EPS -$0.14 | Export Earnings Model | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 1/13/2026 8:56:29 AM | View | Financials | Earnings (Prelim) | SEC | Y 2025 | Export Earnings Model | ||||
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 11/6/2025 4:24:51 PM | Small | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $50,214,000 +11.4% | Assets $196,591,000 | EPS -$0.26 | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 11/6/2025 4:12:02 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $50,214,000 +11.4% | Assets $196,591,000 | EPS -$0.26 | Export Earnings Model | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 8/7/2025 4:35:32 PM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $47,387,000 +6.6% | Assets $206,443,000 | EPS -$0.28 | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 8/7/2025 4:19:34 PM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $47,387,000 +6.6% | Assets $206,443,000 | EPS -$0.28 | Export Earnings Model | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 5/9/2025 4:01:48 AM | Small | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $52,570,000 +2.9% | Assets $205,846,000 | EPS -$0.25 | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 5/8/2025 4:07:14 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $52,570,000 +2.9% | Assets $205,846,000 | EPS -$0.25 | Export Earnings Model | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 4/7/2025 8:11:14 AM | View | Proxy | SEC | Y 2024 | ||||||
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 2/27/2025 4:14:16 PM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $209,357,000 +11.9% | Assets $217,094,000 | EPS -$0.90 | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 2/27/2025 4:10:04 PM | View | Financials | Earnings | SEC | Y 2024 | Rev $68,708,000 +10.4% | Assets $217,094,000 | EPS -$0.01 | Export Earnings Model | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 1/13/2025 8:06:36 AM | View | Financials | Earnings (Prelim) | SEC | Y 2024 | Export Earnings Model | ||||
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 11/5/2024 4:24:04 PM | Small | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $45,086,000 +10.6% | Assets $212,924,000 | EPS -$0.25 | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 11/5/2024 4:07:23 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $45,086,000 +10.6% | Assets $212,924,000 | EPS -$0.25 | Export Earnings Model | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 8/6/2024 4:18:13 PM | Small | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $44,455,000 +6.0% | Assets $226,083,000 | EPS -$0.34 | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 8/6/2024 4:09:43 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $44,455,000 +6.0% | Assets $226,083,000 | EPS -$0.34 | Export Earnings Model | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 5/7/2024 4:24:51 PM | Small | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $51,108,000 +21.1% | Assets $242,726,000 | EPS -$0.30 | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 5/7/2024 4:12:17 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $51,108,000 +21.1% | Assets $242,726,000 | EPS -$0.30 | Export Earnings Model | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 4/2/2024 4:31:04 PM | View | Proxy | SEC | Y 2023 | ||||||
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 2/27/2024 4:45:34 PM | Small | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $187,118,000 +31.9% | Assets $251,907,000 | EPS -$0.81 | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 2/27/2024 4:16:54 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $62,212,000 +25.0% | Assets $251,907,000 | EPS -$0.10 | Export Earnings Model | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 1/8/2024 8:17:47 AM | View | Financials | Earnings (Prelim) | SEC | Y 2023 | Export Earnings Model | ||||
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 11/9/2023 4:26:25 PM | Small | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $40,758,000 +23.3% | Assets $240,360,000 | EPS -$0.28 | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 11/9/2023 4:10:20 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $40,758,000 +23.3% | Assets $240,360,000 | EPS -$0.28 | Export Earnings Model | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 8/9/2023 8:26:03 AM | Small | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $41,953,000 +40.0% | Assets $249,643,000 | EPS -$0.20 | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 8/8/2023 4:14:18 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $41,953,000 +40.0% | Assets $249,643,000 | EPS -$0.20 | Export Earnings Model | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 5/9/2023 8:10:06 AM | Small | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $42,195,000 +45.3% | Assets $249,170,000 | EPS -$0.23 | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 5/8/2023 4:18:35 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $42,195,000 +45.3% | Assets $249,170,000 | EPS -$0.23 | Export Earnings Model | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 4/4/2023 7:21:45 AM | View | Proxy | SEC | Y 2022 | ||||||
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 3/8/2023 9:23:41 AM | Small | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $141,838,000 +50.2% | Assets $159,024,000 | EPS -$0.77 | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 3/7/2023 4:08:41 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $49,769,000 +48.8% | Assets $159,024,000 | EPS -$0.07 | Export Earnings Model | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 1/9/2023 8:08:44 AM | View | Financials | Earnings (Prelim) | SEC | Y 2022 | Export Earnings Model | ||||
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 11/9/2022 8:46:08 AM | Small | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $33,055,000 +52.9% | Assets $156,443,000 | EPS -$0.22 | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 11/8/2022 4:16:40 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $33,055,000 +52.9% | Assets $156,443,000 | EPS -$0.22 | Export Earnings Model | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 8/10/2022 9:28:28 AM | Small | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $29,967,000 +45.1% | Assets $158,722,000 | EPS -$0.31 | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 8/9/2022 8:56:03 PM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $29,967,000 +45.1% | Assets $158,722,000 | EPS -$0.31 | Export Earnings Model | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 5/6/2022 9:19:17 AM | Small | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $29,047,000 +55.3% | Assets $146,512,000 | EPS -$0.16 | |
| Treace Medical Concepts, Inc. (TMCI) | 5/5/2022 4:07:44 PM | View | Financials | Earnings | WIRE | 1Q 2022 | Rev $29,047,000 +55.3% | Assets $146,512,000 | EPS -$0.16 | Export Earnings Model | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 4/4/2022 4:34:08 PM | View | Proxy | SEC | Y 2021 | ||||||
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 3/4/2022 4:21:25 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $94,419,000 +64.6% | Assets $140,821,000 | EPS -$0.43 | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 3/3/2022 4:12:51 PM | View | Financials | Earnings | SEC | Y 2021 | Rev $33,439,000 +38.7% | Assets $140,821,000 | EPS -$0.13 | Export Earnings Model | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 1/12/2022 4:12:06 PM | View | Financials | Earnings (Prelim) | SEC | Y 2021 | Export Earnings Model | ||||
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 11/4/2021 4:33:08 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $21,619,000 +51.5% | Assets $137,590,000 | EPS -$0.12 | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 11/4/2021 4:32:45 PM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $21,619,000 +51.5% | Assets $137,590,000 | EPS -$0.12 | Export Earnings Model | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 8/5/2021 5:00:31 PM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $20,654,000 +166.9% | Assets $142,298,000 | EPS -$0.10 | Export Earnings Model | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 8/5/2021 4:53:58 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $20,654,000 +166.9% | Assets $142,298,000 | EPS -$0.10 | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 5/25/2021 4:13:57 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $18,707,000 +66.2% | Assets $37,382,000 | EPS -$0.07 | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | 5/25/2021 4:06:31 PM | View | Earnings | SEC | 1Q 2021 | Rev $18,707,000 +66.2% | Assets $37,382,000 | EPS -$0.07 |